HEADER SIGNALLING PROTEIN/KINASE 16-MAR-00 1E0A TITLE CDC42 COMPLEXED WITH THE GTPASE BINDING DOMAIN OF P21 ACTIVATED KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION CONTROL PROTEIN 42 HOMOLOG; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 1-184; COMPND 5 SYNONYM: G25K GTP-BINDING PROTEIN; COMPND 6 EC: 3.6.5.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: COMPLEXED WITH 5'-GUANOSYL-IMIDO-TRIPHOSPHATE; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PAK 1; COMPND 12 CHAIN: B; COMPND 13 FRAGMENT: 75-118; COMPND 14 SYNONYM: ALPHA-PAK,PROTEIN KINASE MUK2,P21-ACTIVATED KINASE 1,PAK-1, COMPND 15 P68-PAK; COMPND 16 EC: 2.7.11.1; COMPND 17 ENGINEERED: YES; COMPND 18 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELLULAR_LOCATION: CYTOPLASM; SOURCE 6 GENE: CDC42; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PET16B; SOURCE 13 EXPRESSION_SYSTEM_GENE: CDC42; SOURCE 14 MOL_ID: 2; SOURCE 15 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 16 ORGANISM_COMMON: RAT; SOURCE 17 ORGANISM_TAXID: 10116; SOURCE 18 CELLULAR_LOCATION: CYTOPLASMIC; SOURCE 19 GENE: PAK1; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 22 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 23 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 24 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 25 EXPRESSION_SYSTEM_PLASMID: PGEX2T; SOURCE 26 EXPRESSION_SYSTEM_GENE: PAK KEYWDS SIGNALLING PROTEIN, G PROTEIN SIGNALLING SER/THR KINASE, SIGNALLING KEYWDS 2 PROTEIN-KINASE COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.MORREALE,M.VENKATESAN,H.R.MOTT,D.OWEN,D.NIETLISPACH,P.N.LOWE, AUTHOR 2 E.D.LAUE REVDAT 7 15-MAY-24 1E0A 1 REMARK LINK REVDAT 6 25-SEP-19 1E0A 1 COMPND SOURCE REMARK DBREF REVDAT 6 2 1 SEQADV REVDAT 5 05-FEB-14 1E0A 1 SOURCE REVDAT 4 15-MAY-13 1E0A 1 HEADER COMPND SOURCE KEYWDS REVDAT 4 2 1 AUTHOR JRNL REMARK VERSN REVDAT 4 3 1 DBREF SEQADV FORMUL HELIX REVDAT 4 4 1 SHEET ATOM TER HETATM REVDAT 4 5 1 MASTER REVDAT 3 24-FEB-09 1E0A 1 VERSN REVDAT 2 14-SEP-00 1E0A 1 COMPND REVDAT 1 18-APR-00 1E0A 0 JRNL AUTH A.MORREALE,M.VENKATESAN,H.R.MOTT,D.OWEN,D.NIETLISPACH, JRNL AUTH 2 P.N.LOWE,E.D.LAUE JRNL TITL SOLUTION STRUCTURE OF CDC42 BOUND TO THE GTPASE BINDING JRNL TITL 2 DOMIAN OF PAK JRNL REF NAT.STRUCT.BIOL. V. 7 384 2000 JRNL REFN ISSN 1072-8368 JRNL PMID 10802735 JRNL DOI 10.1038/75158 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE REMARK 4 REMARK 4 1E0A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAR-00. REMARK 100 THE DEPOSITION ID IS D_1290004744. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : 5 MM NA2HPO4, 25MM NACL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 90% WATER, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; TOCSY; TRIPLE RESONANCE REMARK 210 EXPERIMENTS; HNHA REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : AZARA, ANSIG, CNS REMARK 210 METHOD USED : DISTANCE GEOMETRY OF A REMARK 210 SUBSTRUCTURE FOLLOWED BY REMARK 210 CARTESIAN DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : NO VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 7 REMARK 210 REMARK 210 REMARK: SAMPLES WERE 13C,15N LABELLED CDC42 + UNLABELLED PAK OR REMARK 210 13C,15N LABELLED PAK + UNLABELLED CDC42 REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CHAIN A: ENGINEERED MUTATION GLN61LEU REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR A 72 H THR A 75 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 2 140.90 69.44 REMARK 500 1 ALA A 13 84.28 53.41 REMARK 500 1 LYS A 16 -74.19 -62.92 REMARK 500 1 LEU A 19 -73.50 -61.26 REMARK 500 1 THR A 24 -86.23 -123.94 REMARK 500 1 ASN A 26 -56.28 79.03 REMARK 500 1 PRO A 29 165.09 -45.82 REMARK 500 1 SER A 30 -76.44 -119.56 REMARK 500 1 PRO A 34 92.71 -43.81 REMARK 500 1 THR A 35 87.64 -51.98 REMARK 500 1 PHE A 37 -68.76 -146.62 REMARK 500 1 ASP A 38 131.48 60.47 REMARK 500 1 PRO A 50 155.95 -46.38 REMARK 500 1 ALA A 59 -66.71 -127.17 REMARK 500 1 LEU A 61 -53.97 170.48 REMARK 500 1 TYR A 72 102.70 46.29 REMARK 500 1 ASP A 76 -165.40 167.97 REMARK 500 1 VAL A 84 -69.92 -109.09 REMARK 500 1 VAL A 85 -73.73 -52.03 REMARK 500 1 SER A 86 106.16 -50.88 REMARK 500 1 LYS A 94 -70.52 -69.61 REMARK 500 1 CYS A 105 74.49 -152.88 REMARK 500 1 GLN A 116 71.40 177.32 REMARK 500 1 ASP A 121 -47.65 174.65 REMARK 500 1 LYS A 135 168.39 69.77 REMARK 500 1 PRO A 136 92.03 -51.27 REMARK 500 1 LYS A 150 108.94 70.59 REMARK 500 1 LYS A 153 139.77 73.87 REMARK 500 1 ALA A 159 -174.05 -52.16 REMARK 500 1 LEU A 160 -64.91 67.72 REMARK 500 1 GLU A 178 81.83 50.51 REMARK 500 1 PRO A 179 102.58 -46.84 REMARK 500 1 PRO A 182 74.00 -65.29 REMARK 500 1 SER B 74 -83.24 -100.06 REMARK 500 1 PHE B 81 124.06 171.41 REMARK 500 1 HIS B 83 95.65 -68.91 REMARK 500 1 THR B 93 50.42 -155.48 REMARK 500 1 LEU B 107 -69.68 -96.20 REMARK 500 1 GLN B 108 -105.10 -80.40 REMARK 500 1 THR B 109 -24.14 159.34 REMARK 500 1 THR B 113 -63.52 68.99 REMARK 500 1 SER B 115 -82.44 60.80 REMARK 500 2 ASP A 11 -152.31 -60.00 REMARK 500 2 LYS A 16 -73.71 -95.91 REMARK 500 2 LEU A 19 -72.86 -55.71 REMARK 500 2 THR A 24 -88.07 -120.63 REMARK 500 2 ASN A 26 51.91 76.64 REMARK 500 2 PHE A 28 168.39 -45.85 REMARK 500 2 SER A 30 -76.25 -107.44 REMARK 500 2 PRO A 34 91.74 -41.58 REMARK 500 REMARK 500 THIS ENTRY HAS 934 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 186 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 17 OG1 REMARK 620 2 THR A 35 OG1 96.3 REMARK 620 3 GNP A 185 O2G 171.7 89.9 REMARK 620 4 GNP A 185 O2B 89.0 173.3 84.4 REMARK 620 5 HOH A 187 O 93.6 90.2 91.8 93.5 REMARK 620 6 HOH A 188 O 93.5 81.9 81.9 93.8 169.8 REMARK 620 N 1 2 3 4 5 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. STRANDS 1, 2, 3 AND 4 OF SHEET REMARK 700 A1 AND A2 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 186 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNP A 185 REMARK 999 REMARK 999 SEQUENCE REMARK 999 Q61L MUTANT. 7 C-TERMINAL RESIDUES REMOVED REMARK 999 RESIDUES 73 AND 74 ARE FROM THE EXPRESSION SYSTEM DBREF 1E0A A 1 184 UNP P60953 CDC42_HUMAN 1 184 DBREF 1E0A B 75 118 UNP P35465 PAK1_RAT 75 118 SEQADV 1E0A LEU A 61 UNP P60953 GLN 61 ENGINEERED MUTATION SEQADV 1E0A GLY B 73 UNP P35465 EXPRESSION TAG SEQADV 1E0A SER B 74 UNP P35465 EXPRESSION TAG SEQRES 1 A 184 MET GLN THR ILE LYS CYS VAL VAL VAL GLY ASP GLY ALA SEQRES 2 A 184 VAL GLY LYS THR CYS LEU LEU ILE SER TYR THR THR ASN SEQRES 3 A 184 LYS PHE PRO SER GLU TYR VAL PRO THR VAL PHE ASP ASN SEQRES 4 A 184 TYR ALA VAL THR VAL MET ILE GLY GLY GLU PRO TYR THR SEQRES 5 A 184 LEU GLY LEU PHE ASP THR ALA GLY LEU GLU ASP TYR ASP SEQRES 6 A 184 ARG LEU ARG PRO LEU SER TYR PRO GLN THR ASP VAL PHE SEQRES 7 A 184 LEU VAL CYS PHE SER VAL VAL SER PRO SER SER PHE GLU SEQRES 8 A 184 ASN VAL LYS GLU LYS TRP VAL PRO GLU ILE THR HIS HIS SEQRES 9 A 184 CYS PRO LYS THR PRO PHE LEU LEU VAL GLY THR GLN ILE SEQRES 10 A 184 ASP LEU ARG ASP ASP PRO SER THR ILE GLU LYS LEU ALA SEQRES 11 A 184 LYS ASN LYS GLN LYS PRO ILE THR PRO GLU THR ALA GLU SEQRES 12 A 184 LYS LEU ALA ARG ASP LEU LYS ALA VAL LYS TYR VAL GLU SEQRES 13 A 184 CYS SER ALA LEU THR GLN LYS GLY LEU LYS ASN VAL PHE SEQRES 14 A 184 ASP GLU ALA ILE LEU ALA ALA LEU GLU PRO PRO GLU PRO SEQRES 15 A 184 LYS LYS SEQRES 1 B 46 GLY SER ILE SER LEU PRO SER ASP PHE GLU HIS THR ILE SEQRES 2 B 46 HIS VAL GLY PHE ASP ALA VAL THR GLY GLU PHE THR GLY SEQRES 3 B 46 MET PRO GLU GLN TRP ALA ARG LEU LEU GLN THR SER ASN SEQRES 4 B 46 ILE THR LYS SER GLU GLN LYS HET GNP A 185 45 HET MG A 186 1 HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER HETNAM MG MAGNESIUM ION FORMUL 3 GNP C10 H17 N6 O13 P3 FORMUL 4 MG MG 2+ FORMUL 5 HOH *2(H2 O) HELIX 1 1 LYS A 16 TYR A 23 1 8 HELIX 2 2 TYR A 72 ASP A 76 5 5 HELIX 3 3 SER A 86 VAL A 98 1 13 HELIX 4 4 GLU A 100 CYS A 105 1 6 HELIX 5 5 ASP A 122 ALA A 130 1 9 HELIX 6 6 GLU A 140 LYS A 150 1 11 HELIX 7 7 GLY A 164 GLU A 178 1 15 HELIX 8 8 ALA B 91 GLY B 94 5 4 HELIX 9 9 PRO B 100 LEU B 107 1 8 SHEET 1 AA 4 PHE A 56 THR A 58 0 SHEET 2 AA 4 VAL A 7 VAL A 9 1 O VAL A 8 N THR A 58 SHEET 3 AA 4 PHE A 78 LEU A 79 1 O LEU A 79 N VAL A 9 SHEET 4 AA 4 PHE A 110 LEU A 111 1 N LEU A 111 O PHE A 78 SHEET 1 BA 2 GLY B 88 ASP B 90 0 SHEET 2 BA 2 GLU B 95 THR B 97 -1 O GLU B 95 N ASP B 90 LINK OG1 THR A 17 MG MG A 186 1555 1555 2.38 LINK OG1 THR A 35 MG MG A 186 1555 1555 2.40 LINK O2G GNP A 185 MG MG A 186 1555 1555 2.39 LINK O2B GNP A 185 MG MG A 186 1555 1555 2.37 LINK MG MG A 186 O HOH A 187 1555 1555 2.37 LINK MG MG A 186 O HOH A 188 1555 1555 2.37 SITE 1 AC1 5 THR A 17 THR A 35 GNP A 185 HOH A 187 SITE 2 AC1 5 HOH A 188 SITE 1 AC2 21 ALA A 13 THR A 17 CYS A 18 LEU A 19 SITE 2 AC2 21 ILE A 21 SER A 22 TYR A 23 PHE A 28 SITE 3 AC2 21 PRO A 29 THR A 35 CYS A 81 VAL A 113 SITE 4 AC2 21 THR A 115 GLU A 156 CYS A 157 SER A 158 SITE 5 AC2 21 ALA A 159 GLN A 162 LEU A 165 MG A 186 SITE 6 AC2 21 HOH A 188 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1